目的：分析强骨灵胶囊治疗原发性骨质疏松症的临床疗效.方法：取本院于2010年5月30日至2012年5月30日期间门诊及住院收治的原发性骨质疏松症患者120例作为研究对象，所有患者均经临床确诊，根据治疗方法的不同随机分为使用常规治疗的对照组患者以及使用强骨灵胶囊治疗的观察组患者各60例.比较两组患者接受治疗后的临床疗效及不良反应发生情况的差异.结果：观察组患者使用强骨灵胶囊治疗后的效果明显优于使用常规治疗的对照组患者(P<0.05)；观察组患者接受治疗后的不良反应发生率无明显多于对照组患者(P﹥0.05).结论：使用强骨灵胶囊治疗原发性骨质疏松症可以明显提高治疗效果，且不增加不良反应的发生.% Objective: To analyze the strong bone capsule in treating primary osteoporosis clinical efficacy. Methods: The hospital in May 30, 2010 to May 30, 2012 period of outpatient and inpatient treatment of patients with primary osteoporosis 120 cases as the object of study, al the patients were clinicaly diagnosed, according to the different treatments were randomly divided into the control group using conventional treatment of patients and the use of strong bone capsule in treatment of the patients in the observation group 60 cases. Comparison of two groups of patients after treatment of clinical efficacy and adverse reaction incidence differences. Results: The patients in the observation group with a strong bone capsule after treatment is obviously superior to the use of conventional treatment of patients in the control group ( P<0.05 ); the patients in the observation group received treatment after the incidence of adverse reactions in patients without significantly more than the control group ( P﹥0.05 ). Conclusion: The use of Qianggu Capsule in treating primary osteoporosis can obviously improve the therapeutic effect, and does not increase the occurrence of adverse reactions.
展开▼
